New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.
We analyzed the heterogeneity of apo E in very low density lipoprotein from 58 hyperlipidemic subjects with or without atherosclerosis, 69 patients with ischemic heart disease, and 100 apparently healthy individuals. Apo E gene frequencies in the group of healthy individuals were comparable with those in German and American populations. The distribution of six common apo E phenotypes in the groups of hyperlipidemia and ischemic heart disease was similar to that in the healthy group. In addition to the three major isoforms of apolipoprotein E (apo E-4, E-3, and E-2) and the new one (apo E-5) which was recently found in this laboratory, we have discovered an additional series of components, which showed themselves as at least three bands on an isoelectric focusing gel in the region of E-VII through E-V, in four patients with hyperlipidemia and atherosclerosis. The new series of apo E components, named apo E-Suita, was identical with the ordinary apo E in its interaction with heparin-Sepharose gel and with anti-apo E antibody. The most basic component of apo E-Suita (E-VII) was the unsialylated form and other components (E-VI and E-V), the sialylated forms. Family studies revealed that apo E-Suita was determined by inheritance of a new apo E allele located at the same locus as the hitherto known apo E components. Apo E-5 and apo E-Suita isoproteins had isoelectric points more basic than apo E-3, the parent type, by two and four units of charge, respectively. While the apo E-Suita isoprotein had the same molecular weight as ordinary major apo E isoproteins, the molecular weight of the apo E-5 isoprotein was approximately 1,500-2,000 lower than the other apo E isoproteins by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The incidence of abnormal apo E components, including apo E-5 and apo E-Suita, was high among patients with hyperlipidemia and ischemic heart disease (7:127), while we could not find such components among 100 healthy individuals. Moreover, five of seven patients with the abnormal apo E had overt atherosclerotic disease. The findings suggest that these kinds of apolipoprotein mutation are closely related to the development of atherosclerosis.
D000937:Antigen-Antibody Reactions; D001057:Apolipoproteins E / Q000235:genetics* / Q000276:immunology / Q000302:isolation & purification; D001161:Arteriosclerosis / Q000235:genetics*; D003543:Cysteamine / Q000494:pharmacology; D005260:Female; D005787:Gene Frequency; D006801:Humans; D006952:Hyperlipoproteinemia Type III / Q000235:genetics*; D008079:Lipoproteins, VLDL / Q000302:isolation & purification; D008297:Male; D009154:Mutation; D009439:Neuraminidase / Q000494:pharmacology; D010641:Phenotype; D011233:Precipitin Tests
D001057:Apolipoproteins E; D008079:Lipoproteins, VLDL; D003543:Cysteamine; D009439:Neuraminidase